For the first stage of cuts, which calls for an immediate $1 trillion over a decade in exchange for raising the debt ceiling by an additional $900 billion, imaging reimbursement was spared. But that might not be the case for the second stage, according to ACR.
President Obama and congressional lawmakers have agreed on major spending cuts as a part of the debt ceiling deal aimed at staving off a financial default.
The cuts are to happen in two stages. For the first stage, which calls for an immediate $1 trillion over a decade in exchange for raising the debt ceiling by an additional $900 billion, imaging reimbursement was spared. But that might not be the case for the second stage, according to ACR.
The second round of $1.4 to $1.5 trillion in cuts will be identified by a bipartisan “super committee” of House and Senate members. The group is expected to submit its recommendations at the end of November, and those recommendations could include cuts to Medicare, notes Aubrey Westgate at DI's sister publication, Physicians Practice.
“Although successful in averting any cuts associated with the initial $900 billion debt ceiling increase, ACR anticipates that the 12-member super committee undoubtedly will consider changes in Medicare physician reimbursement rates to cut costs,” according to the ACR. “Cuts to imaging will likely be part of a larger package of physician reimbursement reductions.”
If the committee doesn’t reach an agreement, $1.2 trillion in automatic cuts would be applied across the board, and Medicare would be included.
ACR vowed to continue educating lawmakers about “why further cuts to imaging are unnecessary and will adversely impact patient care.”
Have you been following the debt ceiling debate? Are you concerned it could impact imaging? Tell us what you think.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.